S&P 500   3,322.41 (+0.17%)
DOW   29,329.54 (+0.11%)
QQQ   222.40 (+0.05%)
AAPL   315.85 (+0.19%)
FB   220.94 (-0.37%)
MSFT   165.73 (-0.26%)
GOOGL   1,461.62 (+0.79%)
AMZN   1,866.54 (-0.61%)
CGC   24.47 (+0.70%)
NVDA   247.63 (-0.52%)
BABA   226.12 (+0.97%)
MU   57.07 (-1.07%)
GE   11.79 (-0.42%)
TSLA   510.84 (-0.52%)
AMD   50.46 (+1.39%)
T   38.31 (+0.74%)
ACB   2.09 (-2.80%)
F   9.16 (-0.11%)
NFLX   338.24 (-0.11%)
BAC   34.65 (-0.20%)
GILD   62.89 (-0.51%)
DIS   144.88 (-0.17%)
S&P 500   3,322.41 (+0.17%)
DOW   29,329.54 (+0.11%)
QQQ   222.40 (+0.05%)
AAPL   315.85 (+0.19%)
FB   220.94 (-0.37%)
MSFT   165.73 (-0.26%)
GOOGL   1,461.62 (+0.79%)
AMZN   1,866.54 (-0.61%)
CGC   24.47 (+0.70%)
NVDA   247.63 (-0.52%)
BABA   226.12 (+0.97%)
MU   57.07 (-1.07%)
GE   11.79 (-0.42%)
TSLA   510.84 (-0.52%)
AMD   50.46 (+1.39%)
T   38.31 (+0.74%)
ACB   2.09 (-2.80%)
F   9.16 (-0.11%)
NFLX   338.24 (-0.11%)
BAC   34.65 (-0.20%)
GILD   62.89 (-0.51%)
DIS   144.88 (-0.17%)
S&P 500   3,322.41 (+0.17%)
DOW   29,329.54 (+0.11%)
QQQ   222.40 (+0.05%)
AAPL   315.85 (+0.19%)
FB   220.94 (-0.37%)
MSFT   165.73 (-0.26%)
GOOGL   1,461.62 (+0.79%)
AMZN   1,866.54 (-0.61%)
CGC   24.47 (+0.70%)
NVDA   247.63 (-0.52%)
BABA   226.12 (+0.97%)
MU   57.07 (-1.07%)
GE   11.79 (-0.42%)
TSLA   510.84 (-0.52%)
AMD   50.46 (+1.39%)
T   38.31 (+0.74%)
ACB   2.09 (-2.80%)
F   9.16 (-0.11%)
NFLX   338.24 (-0.11%)
BAC   34.65 (-0.20%)
GILD   62.89 (-0.51%)
DIS   144.88 (-0.17%)
S&P 500   3,322.41 (+0.17%)
DOW   29,329.54 (+0.11%)
QQQ   222.40 (+0.05%)
AAPL   315.85 (+0.19%)
FB   220.94 (-0.37%)
MSFT   165.73 (-0.26%)
GOOGL   1,461.62 (+0.79%)
AMZN   1,866.54 (-0.61%)
CGC   24.47 (+0.70%)
NVDA   247.63 (-0.52%)
BABA   226.12 (+0.97%)
MU   57.07 (-1.07%)
GE   11.79 (-0.42%)
TSLA   510.84 (-0.52%)
AMD   50.46 (+1.39%)
T   38.31 (+0.74%)
ACB   2.09 (-2.80%)
F   9.16 (-0.11%)
NFLX   338.24 (-0.11%)
BAC   34.65 (-0.20%)
GILD   62.89 (-0.51%)
DIS   144.88 (-0.17%)
Log in

NASDAQ:ENDP - Endo International Stock Price, Forecast & News

$5.98
-0.20 (-3.24 %)
(As of 01/17/2020 11:38 AM ET)
Today's Range
$5.92
Now: $5.98
$6.31
50-Day Range
$4.32
MA: $4.80
$6.18
52-Week Range
$1.97
Now: $5.98
$12.49
Volume2.89 million shs
Average Volume7.51 million shs
Market Capitalization$1.36 billion
P/E Ratio2.07
Dividend YieldN/A
Beta1.41
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals. The U.S. Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, abuse-deterrent products, liquids, semi-solids, patches, powders, ophthalmics, sprays, and sterile injectables, as well as products for the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
Current SymbolNASDAQ:ENDP
CUSIP29264F20
Phone011-353-1268-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.95 billion
Cash Flow$6.87 per share
Book Value($2.22) per share

Profitability

Net Income$-1,031,470,000.00

Miscellaneous

Employees2,910
Market Cap$1.36 billion
Next Earnings Date2/27/2020 (Estimated)
OptionableOptionable

Receive ENDP News and Ratings via Email

Sign-up to receive the latest news and ratings for ENDP and its competitors with MarketBeat's FREE daily newsletter.


Endo International (NASDAQ:ENDP) Frequently Asked Questions

What is Endo International's stock symbol?

Endo International trades on the NASDAQ under the ticker symbol "ENDP."

How were Endo International's earnings last quarter?

Endo International PLC (NASDAQ:ENDP) announced its quarterly earnings data on Monday, November, 4th. The company reported $0.60 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.53 by $0.07. The company had revenue of $729 million for the quarter, compared to analysts' expectations of $709.01 million. Endo International had a negative return on equity of 99.08% and a negative net margin of 16.89%. Endo International's revenue for the quarter was down 2.1% compared to the same quarter last year. During the same period last year, the firm posted $0.71 EPS. View Endo International's Earnings History.

When is Endo International's next earnings date?

Endo International is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Endo International.

What guidance has Endo International issued on next quarter's earnings?

Endo International updated its FY19 earnings guidance on Monday, November, 4th. The company provided earnings per share guidance of $2.10-2.25 for the period, compared to the Thomson Reuters consensus estimate of $2.16. The company issued revenue guidance of $2.86-2.89 billion, compared to the consensus revenue estimate of $2.86 billion.

What price target have analysts set for ENDP?

13 brokers have issued 1 year price targets for Endo International's stock. Their forecasts range from $2.00 to $15.00. On average, they expect Endo International's share price to reach $7.38 in the next twelve months. This suggests a possible upside of 23.3% from the stock's current price. View Analyst Price Targets for Endo International.

What is the consensus analysts' recommendation for Endo International?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Endo International in the last year. There are currently 2 sell ratings, 8 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Endo International.

Has Endo International been receiving favorable news coverage?

Media headlines about ENDP stock have trended somewhat positive on Friday, InfoTrie reports. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Endo International earned a news impact score of 1.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Endo International.

Are investors shorting Endo International?

Endo International saw a drop in short interest in December. As of December 31st, there was short interest totalling 31,730,000 shares, a drop of 5.6% from the December 15th total of 33,620,000 shares. Based on an average daily trading volume, of 7,940,000 shares, the short-interest ratio is presently 4.0 days. Currently, 15.6% of the shares of the stock are sold short. View Endo International's Current Options Chain.

Who are some of Endo International's key competitors?

What other stocks do shareholders of Endo International own?

Who are Endo International's key executives?

Endo International's management team includes the folowing people:
  • Mr. Paul V. Campanelli, Pres, CEO & Director (Age 57)
  • Mr. Blaise Coleman, Exec. VP & CFO (Age 45)
  • Mr. Terrance J. Coughlin, Exec. VP & COO (Age 53)
  • Mr. Matthew Joseph Maletta, Exec. VP & Chief Legal Officer (Age 47)
  • Mr. Antonio R. Pera, Pres of Par Pharmaceutical (Age 62)

How do I buy shares of Endo International?

Shares of ENDP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Endo International's stock price today?

One share of ENDP stock can currently be purchased for approximately $5.98.

How big of a company is Endo International?

Endo International has a market capitalization of $1.36 billion and generates $2.95 billion in revenue each year. The company earns $-1,031,470,000.00 in net income (profit) each year or $2.89 on an earnings per share basis. Endo International employs 2,910 workers across the globe.View Additional Information About Endo International.

What is Endo International's official website?

The official website for Endo International is http://www.endo.com/.

How can I contact Endo International?

Endo International's mailing address is First Floor Minerva House Simmonscourt Road Ballsbridge, Dublin L2, 19355. The company can be reached via phone at 011-353-1268-2000 or via email at [email protected]


MarketBeat Community Rating for Endo International (NASDAQ ENDP)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  890 (Vote Outperform)
Underperform Votes:  780 (Vote Underperform)
Total Votes:  1,670
MarketBeat's community ratings are surveys of what our community members think about Endo International and other stocks. Vote "Outperform" if you believe ENDP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ENDP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel